Tuesday, July 17, 2007
Glaxo Smith Kline is threatening some lawyers who are advertising for Avandia clients with cease-and-desist letters. I've previously written about Avandia spam (here, here, and here), and about the potential risks of lawyer advertising for clients relating to drugs that are still on the market (here). And Sheila's post yesterday about the increase in spontaneous adverse event reports no doubt reflects some of the publicity confounder, where adverse event reporting increases disproportionately to the actual incidence due to publicity for a medicine.
Worry not, though, there are still plenty of lawyers who would like to talk to you if you Google "Avandia."